Precision medicine is changing the way we understand, diagnose and treat cancer.

The transformation is driven by high-throughput molecular data from patients, animal models, and large-scale experiments. In this program, we will explore how the various ‑omics data types can be analyzed to understand the basic biology associated with cancer onset, development, and outcomes and see how large-scale biomedical data provides an opportunity to improve precision oncology. Details of the program.